v3.22.2.2
Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 13,658,242 $ 8,053,879
Short-term investments 43,789,736 88,324,922
Accounts receivable 5,907,829 66,049
Income tax refund receivable 688,089  
Prepaid expenses and other current assets 2,430,493 2,886,520
Total Current Assets 66,474,389 99,331,370
Property and Equipment, net 20,730,517 2,158,479
Intangible assets, net 9,033,125 3,500,000
Goodwill 3,467,748  
Grant receivable 1,524,522 1,318,359
Operating lease right-of-use asset 2,023,943 1,782,884
Finance lease right-of-use asset 16,645,455 470,700
Other assets   12,193,540
Deposits 265,215 205,901
Total Assets 120,164,914 120,961,233
Current Liabilities    
Accounts payable 3,479,175 922,782
Operating lease liability, current portion 550,128 350,343
Finance lease liability, current portion 328,959 260,574
Accrued expenses and other liabilities 3,823,173 2,419,676
Contingent consideration, current portion 6,269,114 593,037
Contingent consideration, related party - current portion   174,333
Total Current Liabilities 14,450,549 4,720,745
Long Term Liabilities    
Other long-term liabilities   53,530
Derivative warrant liability 274 11,020
Deferred tax liability 3,326,000 215,937
Deferred revenue, net of current portion 751,350 35,000
Operating lease liability, net of current portion 1,173,040 1,060,856
Financing lease liability, net of current portion 6,537,975 255,429
Contingent consideration 10,800,000 1,990,118
Contingent consideration, related party   585,027
Total Liabilities 37,039,188 8,927,662
Stockholders' Equity    
Common stock, $0.0002 par value; 250,000,000 and 250,000,000 shares authorized, 25,614,629 and 25,649,824 shares issued and outstanding at September 30, 2022 and December 31, 2021 5,122 5,055
Additional paid-in capital 281,320,475 278,890,153
Accumulated deficit (197,002,176) (165,718,953)
Accumulated other comprehensive income (loss) 142,304 (67,941)
Total Stockholders' Equity - NightHawk Biosciences, Inc. 84,465,725 113,108,314
Non-Controlling Interest (1,339,999) (1,074,743)
Total Stockholders' Equity 83,125,726 112,033,571
Total Liabilities and Stockholders' Equity $ 120,164,914 $ 120,961,233

Source

PDF HTML 10-Q Filing
ZIP XLS XBRL